Mineralys Therapeutics, Inc.

Nasdaq:MLYS

Pharmaceutical Preparations·RADNOR, PA

CEO

Congleton Jon

Financials

12 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/10/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	2/12/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

12 shown

Filed	Period
11/10/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/12/25	Q2 FY2025	→
2/12/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
8/13/24	Q3 FY2024	→
↓

News (8-K)

28 shown

Filed	Type	Description
3/9/26	Reg FD	Regulation FD Disclosure	→
1/6/26	Reg FD	Regulation FD Disclosure	→
9/3/25	Other	Other Events	→
9/2/25	Other	Other Events	→
6/17/25	Reg FD	Regulation FD Disclosure	→
5/22/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

19 shown

Filed	Form	Description
2/13/26	S-8	S-8	→
11/10/25	S-3ASR	S-3ASR	→
9/3/25	424B5	424B5	→
9/2/25	S-3MEF	S-3MEF	→
9/2/25	424B5	424B5	→
4/9/25	ARS	ARS	→
↓

Filing History(317 filings)

TypeDateAccessionPeriodSize

Mar 10, 2026

0001672659-26-000015FORM 4

Mar 9, 2026

8.2 KB

144

Mar 9, 2026

0001964306-26-000164

—

11.2 KB

8-K

Mar 9, 2026

0001933414-26-0000488-K

Mar 6, 2026

179.3 KB

Mar 4, 2026

0001916048-26-000007FORM 3

Mar 4, 2026

17.9 KB

Feb 20, 2026

0001231919-26-000186

Feb 19, 2026

17.0 KB

Feb 20, 2026

0001933414-26-000045FORM 4

Feb 19, 2026

7.0 KB

Feb 20, 2026

0001933414-26-000044FORM 4

Feb 19, 2026

6.8 KB

Feb 20, 2026

0001933414-26-000043FORM 4

Feb 19, 2026

6.8 KB

Feb 20, 2026

0001933414-26-000042FORM 4

Feb 19, 2026

6.8 KB

Feb 20, 2026

0001933414-26-000041FORM 4

Feb 19, 2026

15.1 KB

Feb 20, 2026

0001933414-26-000040FORM 4

Feb 19, 2026

8.4 KB

Feb 20, 2026

0001933414-26-000039FORM 4

Feb 19, 2026

7.6 KB

Feb 20, 2026

0001933414-26-000038FORM 4

Feb 19, 2026

7.0 KB

Feb 20, 2026

0001933414-26-000037FORM 4

Feb 19, 2026

7.1 KB

Feb 17, 2026

0001672659-26-000013FORM 4

Feb 17, 2026

8.2 KB

144

Feb 17, 2026

0001964306-26-000103

—

10.6 KB

Feb 13, 2026

0001672659-26-000011FORM 4

Feb 12, 2026

22.1 KB

SCHEDULE 13G/A

Feb 13, 2026

0001193125-26-051549

—

11.5 KB

144

Feb 13, 2026

0001964306-26-000097

—

10.5 KB

S-8

Feb 13, 2026

0001933414-26-000010S-8

—

261.6 KB

144

Feb 12, 2026

0001964306-26-000096

—

9.3 KB

Feb 11, 2026

0001933414-26-000007FORM 4

Feb 9, 2026

8.2 KB

144

Feb 9, 2026

0001964306-26-000088

—

8.7 KB

SCHEDULE 13G

Feb 5, 2026

0000315066-26-000484

—

11.2 KB

SCHEDULE 13G

Jan 21, 2026

0002012383-26-000775

—

10.7 KB

25 filings shown

Filed	Form	Description
4/9/25	DEFA14A	DEFA14A	→
4/9/25	DEF 14A	DEF 14A	→
4/9/24	DEFA14A	DEFA14A	→
4/9/24	DEF 14A	DEF 14A	→

Mineralys Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(317 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/10/26	4	4	→
3/4/26	3	FORM 3	→
2/20/26	4	4	→
2/20/26	4	4	→
2/20/26	4	4	→
2/20/26	4	4	→
↓

Filed	Form	Description
3/9/26	144	144	→
2/17/26	144	144	→
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/13/26	144	144	→
2/12/26	144	144	→
2/9/26	144	144	→
↓